To characterize the use of olodaterol and indacaterol in clinical practice and to quantify the
off-label use in asthma. Drug utilization study of new users of olodaterol or indacaterol
between 2014 and 2017 in the PHARMO Database Network in the Netherlands, the Danish
population registers, and the IMS Real-World Evidence Longitudinal Patient Database
panels in France. On-label use was defined as use among adults with a recorded diagnosis
of COPD. Off-label use was defined as use among adults with a recorded diagnosis of …